AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
EFFECTS OF ALTERING THE TIME OF ADMINISTRATION AND THE TIME FRAME OF QUALITY-OF-LIFE ASSESSMENTS IN CLINICAL-TRIALS - AN EXAMPLE USING THE EORTC QLQ-C30 IN A LARGE ANTIEMETIC TRIAL
Authors: PATER J OSOBA D ZEE B LOFTERS W GORE M DEMPSEY E PALMER M CHIN C
Citation: J. Pater et al., EFFECTS OF ALTERING THE TIME OF ADMINISTRATION AND THE TIME FRAME OF QUALITY-OF-LIFE ASSESSMENTS IN CLINICAL-TRIALS - AN EXAMPLE USING THE EORTC QLQ-C30 IN A LARGE ANTIEMETIC TRIAL, Quality of life research, 7(3), 1998, pp. 273-278
QUALITY-OF-LIFE (QL) AS AN END-POINT IN NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP (NCIC CTG) STUDIES - HAVE WE LEARNED ANYTHING NEW
Authors: PATER J BEZJAK A OSOBA D ZEE B PALMER M
Citation: J. Pater et al., QUALITY-OF-LIFE (QL) AS AN END-POINT IN NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP (NCIC CTG) STUDIES - HAVE WE LEARNED ANYTHING NEW, Annals of oncology, 9, 1998, pp. 682-682
QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA
Authors: ZEE B COLE B LI T BROWMAN G JAMES K JOHNSTON D SUGANO D PATER J
Citation: B. Zee et al., QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF INTERFERON MAINTENANCE IN MULTIPLE-MYELOMA, Journal of clinical oncology, 16(8), 1998, pp. 2834-2839
USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY
Authors: LATREILLE J PATER J JOHNSTON D LABERGE F STEWART D RUSTHOVEN J HOSKINS P FINDLAY B MCMURTRIE E YELLE L WILLIAMS C WALDE D ERNST S DHALIWAL H WARR D SHEPHERD F MEE D NISHIMURA L OSOBA D ZEE B
Citation: J. Latreille et al., USE OF DEXAMETHASONE AND GRANISETRON IN THE CONTROL OF DELAYED EMESISFOR PATIENTS WHO RECEIVE HIGHLY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 16(3), 1998, pp. 1174-1178
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA
Authors: CRUMP M GLUCK S PRITCHARD K SHEPHERD L PATER J
Citation: M. Crump et al., HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS HEMATOPOIETIC STEM-CELL SUPPORT FOR BREAST-CANCER IN NORTH-AMERICA, Journal of clinical oncology, 16(2), 1998, pp. 800-801
TOXICITY OF FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - EFFECT OF ADMINISTRATION SCHEDULE AND PROGNOSTIC FACTORS
Authors: LEVY E PIEDBOIS P BUYSE M PIGNON JP ROUGIER P RYAN L HANSEN R ZEE B WEINERMAN B PATER J LEICHMAN C MACDONALD J BENEDETTI J LOKICH J FRYER J BRUFMAN G ISACSON R LAPLANCHE A QUINAUX E THIRION P RYAN L HANSEN R HARRINGTON D MCFADDEN E RIBBLE A JACOBSON R ZEE B WEINERMAN B PATER J LEICHMAN C MACDONALD J BENEDETTI J LOKICH J FRYER J PIGNON JP LAPLANCHE A LUBOINSKI M ROUGIER P BRUFMAN G ISACSON R VAITKEVICIUS V PIEDBOIS P LEBOURGEOIS JP PIEDBOIS Y GAUTHIER E LEVY E THIRION P DURANDZALENSKI I BUYSE M QUINAUX E WOLMARK N PIEDBOIS P BUYSE M CARLSON R RUSTUM Y ERLICHMAN C
Citation: E. Levy et al., TOXICITY OF FLUOROURACIL IN PATIENTS WITH ADVANCED COLORECTAL-CANCER - EFFECT OF ADMINISTRATION SCHEDULE AND PROGNOSTIC FACTORS, Journal of clinical oncology, 16(11), 1998, pp. 3537-3541
CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY
Authors: ZEE B JAMES K PATER J
Citation: B. Zee et al., CAN THE Q-TWIST METHOD PROVIDE INFORMATION ON PATIENTS PREFERENCES WITHOUT COLLECTING PREFERENCE DATA FROM THE PATIENTS - IN REPLY, Journal of clinical oncology, 16(11), 1998, pp. 3718-3718
INTERPRETING THE SIGNIFICANCE OF CHANGES IN HEALTH-RELATED QUALITY-OF-LIFE SCORES
Authors: OSOBA D RODRIGUES G MYLES J ZEE B PATER J
Citation: D. Osoba et al., INTERPRETING THE SIGNIFICANCE OF CHANGES IN HEALTH-RELATED QUALITY-OF-LIFE SCORES, Journal of clinical oncology, 16(1), 1998, pp. 139-144
EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER
Authors: WOLMARK N PIEDBOIS P ROUGIER P BUYSE M PIGNON JP RYAN L HANSEN R ZEE B WEINERMAN B PATER J LEICHMAN C MACDONALD J BENEDETTI J LOKICH J FRYER J BRUFMAN G ISACSON R LAPLANCHE A LEVY E HARRINGTON D MCFADDEN E RIBBLE A JACOBSON R LUBOINSKI M VAITKEVICIUS V LEBOURGEOIS JP PIEDBOIS Y GAUTHIER E DURANDZALESKI I CARLSON R RUSTUM Y ERLICHMAN C
Citation: N. Wolmark et al., EFFICACY OF INTRAVENOUS CONTINUOUS-INFUSION OF FLUOROURACIL COMPARED WITH BOLUS ADMINISTRATION IN ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 301-308
ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER
Authors: PARMAR MKB TORRI V BONAVENTURA A BONAZZI C COLOMBO N DELALOYE JF MARSONI S MANGIONI C SANDERCOCK J SESSA C WILLIAMS C TINAZZI A FLANN M GEISER K SCORPIGLIONE N STEWART JF CHAVES J PALMEIRO E CURTAIN A MCCORMACK T GENNATAS C MARRAS F OPPO TG BALESTRINO M MALZONI C MALZONI M BELLI M GEMINIANI ML CRESTANI G MONACO A VAVALA V PIATTO E BARATTINI G FORNARA PG CHETRI MC SANTEUFEMIA G ARTIOLI F CARONE D FANIZZA G TRENTADUE R PRIOLO D SCOLLO P NIGRO SC PETRINA M MASTRANTONIO P SPANNA GD ZAGNI R BELLONI C COLLEONI R REDAELLI L CAVAGNINI A DICOSTANZO G PERRONI D ARIENTI S ORFANOTTI G CANTONI FM SECLI R BIANCHI A MARTINELLO R MOLLICA G MAIZZI D PICCHIARELLI ME FIORINI G BORSANI M COLOMBO E GARSIA S MELGRATI L PAGGI G BRUNENGHI GM CASINI M ISA L ALGERI R PROZIO G BELFIORE G ANGELINI F DAPRILE M MORESCHI M MAURI ML NATALE N SENZANI FM PAVANATO G POGGI G GARUTI G LUERTI M CRUCIANI G PAGANO F BACCOLO M PODDI ER BOCCIOLONE L SABELLI MA MAGGI R RESTELLI C DANTONA A LOCATELLI MC PESSI A RAINA A CHIARI S GABRIELE A PITTELLI MR IACOBELLI P DOGLIOTTI L GORZEGNO G MUSSO P VEGNA G COCO G ALLETTI DG PICCIOTTO F LUCCHESE V EPIS A DIPALUMBO VS DRUDI G RAVAIOLI A ZAMPELLA D MORANDI MG GORGA G ZUCCHELLI C CARIELLO S GALLETTO L SUSSIO M MASSACESI L MASSACESI M CARLI A TUCCI E TAJANI E CORRADO G BUMMA S DURANDO A MASSOBRIO M SBERVEGLIERI M BIASIO M GUERCIO E JURA R DANESE S WIERDIS T FARNELLI C TARANTINO G GRASSI R REPETTI F ROCCHI B GRAMPA M ERCOLI A GRISO C SIGNORI E ZANINI L PRESTI M KLIMEK M URBANSKI K BISWAS A VIEGAS O KOCHLI O DREHER E FEY M BECK G LUDIN J BONNEFOI H KRAUER F BAUER J DELMORE G FURRER C LORENZ U THURLIMANN B LORENZ U BRONZ L SANNA P WYSS D GOLDHIRSCH A GYR T LEIDI L PASTORELLI G PAGANI O REY P HAILER U BENZ J KAYE SB REED NS SYMONDS RP ATKINSON RJ AXFORD AT RUSTIN G SECKL MJ GREEN JA SCOTT IV GUTHRIE D HARPER PG CALMAN F DOBBS HJ WEIR P CASSONI A LEDERMAN JA SOUHAMI RL BOZZINO J ADAB F REDMAN CWE SCOBLE JE PATERSON M DANIEL F COWLEY N WILLIAMS CJ SPOONER D HONG A MCILLMURRAY M HENDYIBBS P HALL V IVESON TJ WHITEHOUSE JMA GARRY R LAMONT A ROBINSON A TRASK CW CLUBB AW MURRELL D NEWMAN G WILKINS M GOLDTHORP WO ROBERTS JK RADSTONE DJ WHIPP MJ LEDERMANN JA PATER J BUYSE M OMURA G
Citation: Mkb. Parmar et al., ICON2 - RANDOMIZED TRIAL OF SINGLE-AGENT CARBOPLATIN AGAINST 3-DRUG COMBINATION OF CAP (CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN) IN WOMEN WITH OVARIAN-CANCER, Lancet, 352(9140), 1998, pp. 1571-1576
FACTORS PREDICTIVE OF SURVIVAL AFTER FIRST RELAPSE OR PROGRESSION IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A PREDICTION TREE ANALYSIS-DERIVED MODEL WITH TEST AND VALIDATION GROUPS
Authors: HOSKINS P TU D JAMES K PATER J KOSKI B
Citation: P. Hoskins et al., FACTORS PREDICTIVE OF SURVIVAL AFTER FIRST RELAPSE OR PROGRESSION IN ADVANCED EPITHELIAL OVARIAN-CARCINOMA - A PREDICTION TREE ANALYSIS-DERIVED MODEL WITH TEST AND VALIDATION GROUPS, Gynecologic oncology (Print), 70(2), 1998, pp. 224-230
CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS
Authors: AABO K ADAMS M ADNITT P ALBERTS DS ATHANAZZIOU A BARLEY V BELL DR BIANCHI U BOLIS G BRADY MF BRODOVSKY HS BRUCKNER H BUYSE M CANETTA R CHYLAK V COHEN CJ COLOMBO N CONTE PF CROWTHER D EDMONSON JH GENNATAS C GILBEY E GORE M GUTHRIE D KAYE SB LAING AH LANDONI F LEONARD RC LEWIS C LIU PY MANGIONI C MARSONI S MEERPOHL H OMURA GA PARMAR MKB PATER J PECORELLI S PRESTI M SAUERBREI W SKARLOS DV SMALLEY RV SOLOMON HJ STEWART LA STURGEON JFG TATTERSALL MHN WHARTON JT HUININK WWT TOMIROTTI M TORRI W TROPE C TURBOW MM VERMORKEN JB WEBB MJ WILBUR DW WILLIAMS CJ WILTSHAW E YEAP BY
Citation: K. Aabo et al., CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - 4 SYSTEMATIC METAANALYSES OF INDIVIDUAL PATIENT DATA FROM 39 RANDOMIZED TRIALS, British Journal of Cancer, 78(11), 1998, pp. 1479-1487
GENDER AND AGE INFLUENCE BASE-LINE QUALITY-OF-LIFE (QL) ASSESSMENTS IN CANCER-PATIENTS
Authors: DANCEY J ZEE B OSOBA D WHITEHEAD M PALMER M PATER J
Citation: J. Dancey et al., GENDER AND AGE INFLUENCE BASE-LINE QUALITY-OF-LIFE (QL) ASSESSMENTS IN CANCER-PATIENTS, European journal of cancer, 33, 1997, pp. 260-260
EFFECT OF POSTCHEMOTHERAPY NAUSEA AND VOMITING ON HEALTH-RELATED QUALITY-OF-LIFE
Authors: OSOBA D ZEE B WARR D LATREILLE J KAIZER L PATER J
Citation: D. Osoba et al., EFFECT OF POSTCHEMOTHERAPY NAUSEA AND VOMITING ON HEALTH-RELATED QUALITY-OF-LIFE, Supportive care in cancer, 5(4), 1997, pp. 307-313
TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/
Authors: CONNORS JM KLIMO P ADAMS G BURNS BF COOPER I MEYER RM OREILLY SE PATER J QUIRT I SADURA A SHUSTIK C SKILLINGS J SUTCLIFFE S VERMA S YOSHIDA S ZEE B
Citation: Jm. Connors et al., TREATMENT OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY - COMPARISONOF MOPP ABV HYBRID REGIMEN WITH ALTERNATING COURSES OF MOPP AND ABVD - A REPORT FROM THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP/, Journal of clinical oncology, 15(4), 1997, pp. 1638-1645
DETERMINANTS OF POSTCHEMOTHERAPY NAUSEA AND VOMITING IN PATIENTS WITHCANCER
Authors: OSOBA D ZEE B PATER J WARR D LATREILLE J KAIZER L
Citation: D. Osoba et al., DETERMINANTS OF POSTCHEMOTHERAPY NAUSEA AND VOMITING IN PATIENTS WITHCANCER, Journal of clinical oncology, 15(1), 1997, pp. 116-123
GLUCOCORTICOID DOSE-RELATED SUSCEPTIBILITY TO INFECTION IN MYELOMA PATIENTS TREATED WITH MELPHALAN
Authors: SHUSTIK C JOHNSTON D JAMES K ZEE B MYER R BELCH A KLASA R MEHARCHAND J PATER J
Citation: C. Shustik et al., GLUCOCORTICOID DOSE-RELATED SUSCEPTIBILITY TO INFECTION IN MYELOMA PATIENTS TREATED WITH MELPHALAN, Blood, 90(10), 1997, pp. 1596-1596
AN EMPIRICAL-APPROACH TO INFORMED CONSENT IN OVARIAN-CANCER
Authors: FELDMANSTEWART D CHAMMAS S HAYTER C PATER J MACKILLOP WJ
Citation: D. Feldmanstewart et al., AN EMPIRICAL-APPROACH TO INFORMED CONSENT IN OVARIAN-CANCER, Journal of clinical epidemiology, 49(11), 1996, pp. 1259-1269
INFLUENCE OF AGE ON THE TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER
Authors: SIU LL SHEPHERD FA MURRAY N FELD R PATER J ZEE B
Citation: Ll. Siu et al., INFLUENCE OF AGE ON THE TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER, Journal of clinical oncology, 14(3), 1996, pp. 821-828
IMPROVED LOCAL-CONTROL OF INVASIVE BLADDER-CANCER BY CONCURRENT CISPLATIN AND PREOPERATIVE OR DEFINITIVE RADIATION
Authors: COPPIN CML GOSPODAROWICZ MK JAMES K TANNOCK IF ZEE B CARSON J PATER J SULLIVAN LD
Citation: Cml. Coppin et al., IMPROVED LOCAL-CONTROL OF INVASIVE BLADDER-CANCER BY CONCURRENT CISPLATIN AND PREOPERATIVE OR DEFINITIVE RADIATION, Journal of clinical oncology, 14(11), 1996, pp. 2901-2907
INCREASED THROMBOEMBOLIC COMPLICATIONS WITH CONCURRENT TAMOXIFEN AND CHEMOTHERAPY IN A RANDOMIZED TRIAL OF ADJUVANT THERAPY FOR WOMEN WITH BREAST-CANCER
Authors: PRITCHARD KI PATERSON AHG PAUL NA ZEE B FINE S PATER J
Citation: Ki. Pritchard et al., INCREASED THROMBOEMBOLIC COMPLICATIONS WITH CONCURRENT TAMOXIFEN AND CHEMOTHERAPY IN A RANDOMIZED TRIAL OF ADJUVANT THERAPY FOR WOMEN WITH BREAST-CANCER, Journal of clinical oncology, 14(10), 1996, pp. 2731-2737
ASSOCIATION BETWEEN CAPSULE DIAMETER, ADEQUACY OF ENCAPSULATION, AND SURVIVAL OF MICROENCAPSULATED RAT ISLET ALLOGRAFTS
Authors: DEVOS P DEHAAN B PATER J VANSCHILFGAARDE R
Citation: P. Devos et al., ASSOCIATION BETWEEN CAPSULE DIAMETER, ADEQUACY OF ENCAPSULATION, AND SURVIVAL OF MICROENCAPSULATED RAT ISLET ALLOGRAFTS, Transplantation, 62(7), 1996, pp. 893-899
QUALITY-OF-LIFE STUDIES IN CHEMOTHERAPY-INDUCED EMESIS
Authors: OSOBA D ZEE B WARR D KAIZER L LATREILLE J PATER J
Citation: D. Osoba et al., QUALITY-OF-LIFE STUDIES IN CHEMOTHERAPY-INDUCED EMESIS, Oncology, 53, 1996, pp. 92-95
QUINOLONE-BASED ANTIBACTERIAL CHEMOPROPHYLAXIS IN NEUTROPENIC PATIENTS - EFFECT OF AUGMENTED GRAM-POSITIVE ACTIVITY ON INFECTIOUS MORBIDITY
Authors: BOW EJ MANDELL LA LOUIE TJ FELD R PALMER M ZEE B PATER J
Citation: Ej. Bow et al., QUINOLONE-BASED ANTIBACTERIAL CHEMOPROPHYLAXIS IN NEUTROPENIC PATIENTS - EFFECT OF AUGMENTED GRAM-POSITIVE ACTIVITY ON INFECTIOUS MORBIDITY, Annals of internal medicine, 125(3), 1996, pp. 183
CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS
Authors: ALBERTI W ANDERSON G BARTOLUCCI A BELL D VILLALBA JB BRODIN O CARDIELLO C CARTEI F CARTEI G CELLERINO R CHASTANG C CORMIER Y COX JD CRINO L CROWLEY J DAUTZENBERG B DEPIERRE A DIETEMANN A DILLMAN RO DOI O FELD R FIGLIN R GANZ PA GREEN MR GREGOR A HELLE PA HERNDON JE HITOMI S HOST H IMAIZUMI M JETT JR JOHNSON D KAASA S KIMURA H KLASTERSKY J KONDO H KREISMAN H KRIS MG KUNISHIMA K KUWAHARA O LAD TE LAING AH MACBETH F MASAOKA A MATTSON K MINATEL E MIRA JG MORI T MOUNTAIN CF NIEDERLE N NIIRANEN A NOU E PAGE W PATER J PIANTADOSI S PISTERS KMW PYRHONEN S QUOIX E RAPP E ROWELL NP SAHMOUD T SAWAMURA K SCHALLIER DCC SCOTT C SIMPSON J STAGG M TERAMATSU T TROVO MG TSUCHIYA R TUMMARELLO D VANHOUTTE P VANZANDWIJK N VINCENT RG WADA H WHITE JE WILLIAMS CJ WOODS RL YAMAGUCHI Y ARRIAGADA R CARTMELLDAVIES J GIRLING DJ LECHEVALIER T MARSONI S PARMAR MKB PIGNON JP REKACEWICZ C SOUHAMI RL STEWART LA TARAYRE M TINAZZI A TONI V
Citation: W. Alberti et al., CHEMOTHERAPY IN NON-SMALL-CELL LUNG-CANCER - A METAANALYSIS USING UPDATED DATA ON INDIVIDUAL PATIENTS FROM 52 RANDOMIZED CLINICAL-TRIALS, BMJ. British medical journal, 311(7010), 1995, pp. 899-909
Risultati: 1-25 | 26-38